Streetwise Reports' Article Archives — February 2020 back to current month (28)

Sangamo Shares Trade 30% Higher on Q4 Earnings and Biogen Collaboration (02/28/2020)

Sangamo Therapeutics shares traded higher after the company reported Q4/19 and FY/19 earnings and advised that it signed a global collaboration agreement with Biogen to develop gene regulation therapies for Alzheimer's, Parkinson's, neuromuscular and neurological diseases.


Teladoc Shares Trade 20% Higher on Virtual Medicine Tailwinds and Q4 Earnings (02/27/2020)

Shares of Teladoc Health climbed to a new 52-week high price after the firm reported Q4/19 and FY/19 financial results that included a 32% year-over-year increase in revenue and a 57% increase in patient visits.


Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor (02/26/2020)

Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle coaching for people with Type 2 diabetes and prediabetes.


Mobile Health and Telemedicine Provider for Community-Based Healthcare Teams Up with US Health Data Firm (02/26/2020)

Reliq Health Technologies advised that it has been selected as remote patient monitoring and chronic care management solutions partner by U.S. health data company MaxMD.


Moderna Shares Climb on Development of mRNA Vaccine for Phase 1 Coronavirus Study (02/25/2020)

Shares of Moderna traded 23% higher after the company reported that it has developed and shipped an mRNA vaccine against novel coronavirus for use in a Phase 1 testing study in the U.S.


Two Stock-Moving Catalysts Expected in March for Biopharma (02/25/2020)

These events for Axsome Therapeutics are described in an H.C. Wainwright & Co. report.


NGM Biopharma Shares Rise on Positive Topline Data from Phase 2 NASH Trial (02/24/2020)

Shares of NGM Biopharmaceuticals reached a new 52-week intraday high price after the company posted positive topline data from Cohort 4 of its Phase 2 study of aldafermin in NASH Patients.


Antibiotic-Free Feed Additive Shows Benefit in Cow Mastitis Trial (02/24/2020)

Avivagen's proprietary product yielded statistically significant results.


Healthcare Tech Firm Lands Contract in Florida (02/22/2020)

Reliq Health Technologies will provide the client with two telehealth platforms.


Tech Firm Announces New Deals Worth $1 Million (02/21/2020)

These newly signed contracts of HealthSpace Data Systems are with governmental agencies in two U.S. states.


Mobile/Telehealth Tech Firm Makes Stock Exchange's Top 10 (02/21/2020)

Reliq Health Technologies is chosen based on three criteria.


Healthcare Firm Changes Name to Reflect Digital Health and Telemedicine Focus (02/21/2020)

Premier Health Group announced that it changed its name to CloudMD Software & Services Inc., and trading under the symbol DOC will begin Feb. 24.


Baudax Shares Rise as FDA Approves NDA for Its Non-Opioid Pain Medication (02/21/2020)

Shares of Baudax Bio traded more than 20% higher and set a new 52-week high price after reporting that the FDA approved the company's non-opioid ANJESO™ drug for management of moderate to severe pain.


FDA Approval of Biopharma's Pain Drug Expected This Year (02/19/2020)

The reasons a green light is anticipated and how it relates to the closing of Avenue Therapeutics' pending acquisition are discussed in an H.C. Wainwright & Co. report.


The 'Virus' Technology That Kills Coronavirus Plus Lots of Other Pathogens (02/18/2020)

Fincom Investment Partners profiles TOMI Environmental Solutions, whose SteraMist disinfectant technology kills the coronavirus.


Viela Bio Shares Trade Higher After Analyst Issues 'Buy' Recommendation (02/18/2020)

Shares of Viela Bio Inc. rose 20% after an analyst at H.C. Wainwright & Co. initiated coverage of the stock.


Life Sciences Firm Contracts with Philippines Distributor (02/18/2020)

This agreement will provide another sales channel and additional revenue opportunities for Avivagen's proprietary product.


ImmunoGen Shares Rise 25% on FY/19 Financial Results and Clinical Pipeline Updates (02/14/2020)

Shares of ImmunoGen Inc. reached a new 52-week intraday high price after the company announced FY/19 financial results and reported on recent developments including the completion of a $97.6 million capital raise in January 2020.


vTv Therapeutics' Shares Open 80% Higher on Phase 2 Type 1 Diabetes Trial Data (02/10/2020)

Shares of vTv Therapeutics traded 50% higher after the company reported positive results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399 used in the treatment of patients with type 1 diabetes.


Biopharma Has Three 2020 Shots on Goal in Pediatric Liver Diseases (02/08/2020)

The events in that trio are presented in a ROTH Capital Partners report.


Telehealth Solutions Firm Gains Further Customer Traction in Texas (02/07/2020)

With the added clients, the company will expand into two more clinical realms.


Myriad Genetics Shares Fall 30% on Q2 Earnings and Executive Leadership Change (02/07/2020)

Shares of Myriad Genetics traded 30% lower after the firm released Q2/20 earnings and announced the appointment of a new interim CEO.


Cortexyme Secures $125M Private Placement Capital to Advance Clinical Development (02/06/2020)

Shares of Cortexyme Inc. traded 20% higher after the company reported that it secured an additional $125M in capital from a private placement. The firm intends to use the proceeds to fund current Alzheimer's clinical trials and ongoing operations.


Vivus Shares Climb 50% Higher on sNDA Approval for Exocrine Pancreatic Insufficiency Drug (02/05/2020)

Shares of Vivus traded higher after the FDA approved the company's supplemental New Drug Application for an improved formulation of PANCREAZE® (pancrelipase) for use in the treatment of exocrine pancreatic insufficiency due to cystic fibrosis and other conditions.


Understanding Fortress Biotech (02/05/2020)

Daniel Carlson of Tailwinds Research takes a close look at what he calls a "great value opportunity," with a focus on subsidiary Avenue Therapeutics.


MedTech Company Launches Direct to Consumer Telemedicine App (02/05/2020)

The product is initially available to residents of British Columbia.


Rapidly Growing Healthcare Tech Firm Appoints President (02/04/2020)

The appointed physician will be tasked with developing global business for the company.


Insmed Shares Trade 40% Higher on Phase 2 Top-Line Bronchiectasis Trial Data (02/03/2020)

Insmed Inc.'s shares traded higher today after the company reported positive top-line results from its Phase 2 WILLOW Study of INS1007 in patients with non-cystic fibrosis bronchiectasis.


More Archives

2024Jun May Apr Mar Feb Jan

2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes